New York, February 6, 2026, 06:55 EST — Premarket
- Oscar Health shares dipped roughly 2% in premarket trading, following a drop of over 5% on Thursday.
- Managed-care shares took a hit after new warnings about rising medical costs and disappointing profit forecasts for 2026.
- Investors are zeroing in on Oscar’s Feb. 10 earnings, seeking hints on 2026 enrollment and claims patterns.
Oscar Health, Inc. shares dipped 2.3% in premarket action Friday, slipping to $12.22 following a 5.4% drop to $12.51 in the previous session.
Shares tumbled as investors reacted to fresh signs of rising costs hitting U.S. health insurers. Molina Healthcare warned late Thursday that its 2026 profits will fall well short of Wall Street’s forecasts and announced plans to exit traditional Medicare Advantage Part D plans by 2027. The news sent Molina’s stock down nearly 35% in after-hours trading and dragged other insurers lower. “We believe that the imbalance between rates and trend marks 2026 as a trough year for Medicaid industry margins,” CEO Joseph Zubretsky said. Reuters
Oscar faces a tricky timing issue. The company plans to report its fourth-quarter and full-year 2025 results ahead of the market open on Tuesday, Feb. 10, with a conference call set for 8:00 a.m. ET.
Policy risk remains a real concern. Senate negotiations to revive expired Affordable Care Act subsidies have effectively fallen apart, KFF Health News reports, citing lawmakers. As a result, about 20 million Americans lost access to the enhanced tax credits at the end of 2025.
Other insurer news this week stayed centered on medical costs. Cigna beat quarterly estimates but gave a cautious 2026 outlook. Oppenheimer’s Michael Wiederhorn said the firm “appears to be on-track” with its new model, despite anticipating headwinds next year. CFO Ann Dennison noted the outlook includes “appropriate prudence given the continued elevated cost environment.” Reuters
Oscar’s shares slipped for a second day, ending Wednesday at $13.22 before dropping to $12.51 on Thursday.
Oscar offers individual and family health plans, including those purchased via Affordable Care Act marketplaces, making it more vulnerable than some competitors to fluctuations in exchange enrollment and pricing trends.
As Friday’s session begins, traders are focused on whether the managed-care selloff that hit Molina after hours will spill into regular trading. All eyes are also on Oscar, to see if it follows that downward move or attracts buyers after its steep two-day drop.
Thin premarket volume tends to amplify price swings, and for Oscar, the next trigger hinges on company-specific factors. If there are signs of rising claims costs, declining membership, or a harsher pricing environment for 2026, the slide could deepen. On the flip side, stable cost trends or a more favorable enrollment picture might ease the pressure.
